ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer
scientific article published on November 21, 2015
Author/s
author: Giuseppe Viale, Patrick Neven, Olivia Pagani, Aron Goldhirsch, Meredith M Regan, Karen L Price, Roswitha Kammler, Patrizia Dell'Orto, Brian Leyland-Jones, Mark Abramovitz, Mark Bouzyk, Brandon M Young, Bradley A Long, Maria Olivia Biasi, Beat Thürlimann, James M Rae, Vernon Harvey
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.